Skip to main content

Yes Bank FPO shares to list on July 27; stock plunges 49% in 2 weeks

The price band was Rs 12-13 and the share price was Rs 30.45 on June 10. Hence, the correction till around its issue price was on expected lines.

Shares allotted in the follow-on public offer of Yes Bank will list on the bourses on July 27.

The private sector lender raised Rs 14,272 crore through its latest FPO which was subscribed 95 percent during July 15-17.

The issue size was Rs 15,000 crore, so the balance amount would have be contributed by its issue underwriter SBI Capital Markets. In the issue prospectus, SBI Capital Markets committed underwriting amount of up to Rs 3,000 crore.

The final issue price has been fixed at Rs 12 per share, the lower end of the price band of Rs 12-13. Employees received shares at Re 1 discount to issue price.

FPO shares were allotted to eligible participants in the issue on July 23 and the same shares were credited to their accounts on July 24.


"Securities of Yes Bank are listed and admitted for trading on the exchange with effect from July 27, 2020. These shares rank pari-passu with the existing equity shares of the company," said the BSE in its release.

Yes Bank, which raised Rs 4,098 crore through anchor book and rest through the issue during July 15-17, was subscribed 93 percent while including anchor book, the subscription stood at 95 percent largely supported by QIB category which saw subscription of 1.90 times.

State Bank of India is the largest shareholder in Yes Bank with 48.21 percent stake followed by ICICI Bank, HDFC, Axis Bank, Kotak Mahindra Bank, Bandhan Bank, Federal Bank and IDFC First Bank, which all invested Rs 10,000 crore in Yes Bank under Reconstruction Scheme in March this year.

Yes Bank share price has been corrected consistently since July 10, losing 48.8 percent to close at Rs 13.65 on July 24. It shed 55 percent since the announcement of FPO price band on June 10.

The price band was Rs 12-13 and the share price was Rs 30.45 on June 10. Hence, the correction till around its issue price was on expected lines.

Source - Moneycontrol.com

 


Labels:

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...
Post a Comment
Read more